EAST.V - EastWest Bioscience Inc.
| Previous Close | 0.0650 |
| Open | 0.0650 |
| Bid | 0.0600 x 0 |
| Ask | 0.0650 x 0 |
| Day's Range | 0.0600 - 0.0600 |
| 52 Week Range | 0.0550 - 0.3850 |
| Volume | 35,000 |
| Avg. Volume | 172,471 |
| Market Cap | 4.894M |
| Beta (3Y Monthly) | N/A |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0570 |
| Earnings Date | Oct 1, 2019 - Oct 4, 2019 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Simply Wall St.•15 days ago
How Financially Strong Is EastWest Bioscience Inc. (CVE:EAST)?
While small-cap stocks, such as EastWest Bioscience Inc. (CVE:EAST) with its market cap of CA$6.1m, are popular for...
- ACCESSWIRE•16 days ago
EastWest Bioscience Reports Third Quarter 2019 Financial Results
VANCOUVER, BC / ACCESSWIRE / July 4, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) expands on its vision, strategy, and outlook for the future and comments on its 3Q financial results for the three months ended April 30, 2019. "US Approval was a tremendous achievement this quarter," explains Rodney Gelineau, CEO of EastWest Bioscience. Eastwest concluded its Joint Venture agreement with Azema Sciences, allowing it to start the production of CBD from its Kentucky facility, for its line of consumer products.
- ACCESSWIRE•23 days ago
EastWest Science USA Signs Mutual US Distribution Agreement with CBD Manufacturer GM Health Wholesale
VANCOUVER, BC / ACCESSWIRE / June 27, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that its subsidiary EastWest Science USA has signed a mutual distributor agreement with GM Health Wholesale ("GM Health") (www.gmhempco.com), a Kentucky company and a leading manufacturer and wholesaler of CBD Tinctures, Creams, Salves and Capsules. Under the terms of this agreement GM Health will become a distributor of EastWest's products and EastWest will become a global distributor for GM Health's all-natural CBD products.
- ACCESSWIRE•25 days ago
EastWest Bioscience Starts Production of CBD Pet Treats for the US Market
VANCOUVER, BC / ACCESSWIRE / June 25, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that, further to its News Release on April 26th, 2019, that the Company has started production of CBD infused Chill Dog and Quick Cat for the US Market. +CBD Chill Dog and +CBD Quick Cat will be sold through the company's Kentucky based distribution arm, EastWest Science USA. EastWest is working with distributors in the US for product launch pre-orders.
- ACCESSWIRE•26 days ago
EastWest Bioscience Continues Expansion in Western Canada Through Avafina Pet Products
VANCOUVER, BC / ACCESSWIRE / June 24, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that it has partnered with Avafina Pet Products ("Avafina") (www.avafinapet.com) to distribute its Natural Pet Science line of pet treats into more than 300 stores across Western Canada. Avafina's passionate and knowledgeable sales professionals, along with their distribution centre in Coquitlam, BC, provides a strategic distribution and sales partnership into the independent and retail chain channel for EastWest. Avafina's customer base includes strong independent pet food retailers along with some of the largest growing pet chains in Canada.
- ACCESSWIRE•last month
EastWest Bioscience Signs Definitive Joint Venture Agreement with Azema Sciences; US Expansion Story Continues
VANCOUVER, BC / ACCESSWIRE / June 20, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that, further to its News Release on April 30th, 2019 that the Company has signed a Definitive Agreement with Azema Sciences Inc. ("Azema" or "Azema Sciences") to Joint Venture on a preferred supply and distribution agreement, specifically for the supply of bulk CBD and finished CBD products, and distribution throughout the US and Globally. EastWest is entering into a Joint Venture with Azema, securing for EastWest first rights on Azema's output of bulk CBD and finished CBD products which are ready for sale in the USA and globally.
- ACCESSWIRE•last month
DTC Application Update: EastWest Bioscience Passes Due Diligence for FINRA Form 15c-211
VANCOUVER, BC / ACCESSWIRE / June 19, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that, further to its News Release on May 7th 2019, it has passed third party due diligence pursuant to FINRA Rule 15c2‐11 ("Form 211"), as part of the Company's DTC application. Form 211 clearance is important as it requires the Directors and Principals of EAST, in addition to the Company itself to pass the regulatory background checks and due diligence necessary to list in the U.S. Form 211 clearance opens the way for EAST to complete the DTC's due diligence and subsequently finalize the Company's application for listing on the OTC Markets QB Exchange.
- ACCESSWIRE•last month
EastWest Bioscience Continues Global Expansion Through a Distribution Agreement with New Zealand Hemp Brokers
VANCOUVER, BC / ACCESSWIRE / June 18, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (EAST.V) announces that it has signed a distributor agreement with New Zealand Hemp Brokers (NZHB) (www.nzhempbrokers.com), a leading wholesaler and New Zealand's only specialist Hemp Broker with reach into important key markets in New Zealand, Australia, and Asia. NZHB are experts in the distribution, import and export of industrial hemp (iHemp) and hemp products. EastWest will begin shipping Earth's Menu, Natural Pet Science, Chanvre Hemp and Natural Advancement products within the next 2 months with plans to ship CBD products, currently in various stages of formulation and manufacturing, from the United States.
- ACCESSWIRE•last month
EastWest Bioscience Receives TSX Approval for Operations in 20 Additional US States.
VANCOUVER, BC / ACCESSWIRE / June 12, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) expands into 20 Additional US States with TSX approval. On June 6th, 2019, ...
- ACCESSWIRE•last month
EastWest Bioscience signs Letter of Intent with Benchmark Botanics
VANCOUVER, BC / ACCESSWIRE / June 10, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that it has signed a Letter of Intent for a J oint V enture with Benchmark Botanics Inc. ("Benchmark") (CSE:BBT) for the purposes of Cannabis Act licensing, joint product development, and product distribution to national and international markets. EastWest and Benchmark are excited to be aligning their Canadian businesses across multiple stages of the product lifecycle. Benchmark Botanics' 100% owned subsidiary, Potanicals Green Growers Inc. is a Health Canada licensed producer under the Cannabis Act , located in Peachland, BC, a 45- minute drive from the facility owned and operated by EastWest in Penticton, BC. Benchmark also continues with their greenhouse construction in Pitt Meadows, BC.
- ACCESSWIRE•2 months ago
EastWest Bioscience Signs Letter of Intent to Joint Venture with Continental Agro Trade Corporation a Canadian Industrial Hemp Grower
VANCOUVER, BC / ACCESSWIRE / May 15, 2019 / EastWest Bioscience (the "Company"or "EastWest") (TSX.V: EAST) announces that on May 13, 2019 they signed a Letter of Intent to joint venture ...
- ACCESSWIRE•2 months ago
EastWest Bioscience Contracts Internal Investor Relations Representative
VANCOUVER, BC / ACCESSWIRE / May 14, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) advises that on February 1, 2019 the Company contracted Mr. Nicholas Vincent, ...
- ACCESSWIRE•2 months ago
EastWest Bioscience Inc. Announces Submission of DTC and OTCQB Venture Market Applications
VANCOUVER, BC / ACCESSWIRE / May 7, 2019 / EastWest BioScience Inc. ("Company" or "EastWest") (TSXV: EAST) announces its eligibility to The Depository Trust Company ("DTC") ...
- ACCESSWIRE•3 months ago
EastWest Bioscience Signs Joint Venture Intent with US CBD Manufacturer Azema Sciences Inc.
VANCOUVER, BC / ACCESSWIRE / April 30, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces that on April 29, 2019 they signed an LOI with Azema Sciences Inc. ("Azema" or "Azema Sciences") to Joint Venture on a preferred supply and distribution agreement for bulk CBD and finished CBD products throughout the US and Globally. EastWest is entering into a joint venture with Azema, securing for EastWest first rights on Azema's output of bulk CBD and finished CBD products manufactured, and which are ready for sale in the USA and globally.
- ACCESSWIRE•3 months ago
EastWest Bioscience Adds to CBD Pet Product Line and Leverages FDA Green Light on Hemp Seed in the USA
VANCOUVER, BC / ACCESSWIRE / April 26, 2019 / EastWest Bioscience (the "Company"or "EastWest") (TSX.V: EAST) announces four additional products to its Natural Pet Science line, both ...
- ACCESSWIRE•3 months ago
EastWest Bioscience Incorporates US Company in Kentucky for US Operations and CBD Product Development
VANCOUVER, BC / ACCESSWIRE / April 17, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX-V: EAST) is moving rapidly on the recent TSX-V approval allowing EastWest to operate ...
- ACCESSWIRE•3 months ago
EastWest Bioscience Restructures its Board for Expansion into the US and EU CBD Markets
VANCOUVER, BC / ACCESSWIRE / April 15, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) announces today the appointment of two new independent Directors, Paul Mandl and Jeff Bierman, to the Board. Both these new board members will help to ensure the Company is well-equipped to efficiently execute its expansion into the US and EU. Douglas Horne, who served as an independent on the Company's board since March 2017 has resigned from the board for health reasons.
- ACCESSWIRE•3 months ago
EastWest Bioscience Receives TSX Approval for Operations in Kentucky, USA with Eight New CBD Products
VANCOUVER, BC / ACCESSWIRE / April 10, 2019 / EastWest Bioscience (the "Company" or "EastWest") (EAST.V) expands into Kentucky, USA with TSX approval. On April 1st, 2019, the TSX Venture Exchange gave EastWest Bioscience Inc. the green light to sell its products containing CBD in Kentucky, USA. Until recently, because of rules imposed by the TSX due to legal uncertainty regarding business operations involving any products derived from hemp, the Company was restricted from doing business in the USA.
- ACCESSWIRE•3 months ago
EastWest Comments on 2Q Financial Statements and Expands on Vision, Strategy, and Execution
VANCOUVER, BC / ACCESSWIRE / April 8, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) expands on its vision, strategy, and outlook for the future and comments ...
- ACCESSWIRE•4 months ago
EastWest Announces Completion of Unit Offering
VANCOUVER BC / ACCESSWIRE / April 3, 2019 / Vancouver, BC: EASTWEST BIOSCIENCE INC. (the "Corporation")(EAST.V) today announced that it is has completed the sale of2,283,168 units of the Corporation ("Units") at aprice of $0.15 per Unit for aggregate gross proceeds of $342,475.Each Unit consists of one common share in the capital of theCorporation ("Common Share") and one-half of oneshare purchase warrant, with each whole warrant("Warrant") entitling the holder thereof topurchase an additional Common Share at an exercise price of $0.20per share for a period of two years from the date of itsissuance. The Corporation issued finders fees of $6,250 and 41,658 finders' warrants ("Finder's Warrants") to persons whointroduced the Corporation to subscribers who purchased Units underthe Offering. Each Finder's Warrant entitles the holder thereof topurchase a Common Share at an exercise price of $0.20 for a periodof two years.
- ACCESSWIRE•4 months ago
A Message from the CEO - EastWest's Corporate Update on its Vision, Strategy, and Execution
VANCOUVER, BC / ACCESSWIRE / March 28, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (EAST.V) President and CEO Rodney Gelineau gives a corporate update. It is paving the way to accelerated CBD product releases into domestic and international markets.
- ACCESSWIRE•4 months ago
EastWest Bioscience Receives First Scheduled Purchase Order from Major Pet Products Distributor Natural Pet Distributors
VANCOUVER, BC / ACCESSWIRE / March 7, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (TSX-V: EAST) has received its first order from Natural Pet Distributors ("NPD") ...
- ACCESSWIRE•5 months ago
EastWest Bioscience Receives New PO’s from Global Retailer the TJX Companies Inc to Increase Canada Wide Distribution
VANCOUVER, BC / ACCESSWIRE / March 1, 2019 / EastWest Bioscience Inc. (the "Company" or "EastWest") (EAST.V) announces that the Company has received several new purchase orders for its hemp-based consumer goods from global retailer The TJX Companies, Inc (NYSE:TJX), the leading mass retailer of apparel and home fashions in the U.S. and worldwide. "With this new purchase order and our success at introducing two new hemp-based consumer product lines at the CHFA West natural health foods show in Vancouver last week, we continue to broaden our sales and reach into Canadian consumer markets," says Rodney Gelineau, EastWest's CEO.
- ACCESSWIRE•5 months ago
EastWest Bioscience Attends CHFA West Natural Health Product Show to Introduce its Newest Hemp-based Food and Body Care Products
VANCOUVER. BC / ACCESSWIRE / February 22, 2019 / EastWest Bioscience (the "Company" or "EastWest") (TSX.V: EAST) announces it will be attending the Canadian Health Foods Association ...
- ACCESSWIRE•5 months ago
EastWest Announces Appointment of New Chief Operating Officer
VANCOUVER, BC / ACCESSWIRE / February 19, 2019 / EastWest Bioscience Inc. (the " Company " or " EastWest ") (TSXV: EAST) is pleased to announce that Ms. Ciska Asriel has been appointed ...
